Detalhe da pesquisa
1.
Dual targeting of GSK3B and HDACs reduces tumor growth and improves survival in an ovarian cancer mouse model.
Gynecol Oncol
; 159(1): 277-284, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32698955
2.
An Inhibitor of GSK3B and HDACs Kills Pancreatic Cancer Cells and Slows Pancreatic Tumor Growth and Metastasis in Mice.
Gastroenterology
; 155(6): 1985-1998.e5, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30144430
3.
Interplay in galectin expression predicts patient outcomes in a spatially restricted manner in PDAC.
Biomed Pharmacother
; 172: 116283, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38377735
4.
Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma.
Elife
; 122023 06 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37350578